← Back to Search

Behavioural Intervention

Exercise for Sarcopenia

N/A

Waitlist Available

Research Sponsored by University of Texas at Austin

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up one month

Awards & highlights

Study Summary

This trial will study the effects of varying levels of physical activity on lipid metabolism in older men and women, as well as the effects of exercise training on muscle mass and function in a separate group of older adults.

Who is the study for?

This trial is for relatively healthy men and women aged between 60-80 years who are interested in participating in an exercise program to combat muscle loss (sarcopenia) and improve heart health. Those considered relatively unhealthy cannot participate.Check my eligibility

What is being tested?

The study involves two parts: initially, participants will vary their daily physical activity while researchers study changes in fat metabolism. Then, a second group will undergo six months of exercise training aimed at increasing cycling power to see how it affects muscle mass and function.See study design

What are the potential side effects?

Since the intervention is exercise-based, potential side effects may include typical workout-related issues such as muscle soreness, fatigue, or injury if not performed correctly. However, these risks are generally low.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ six months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~six months

This trial's timeline: 3 weeks for screening, Varies for treatment, and six months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Muscle mass

Post-prandial lipemia

Trial Design

1Treatment groups

Experimental Treatment

Group I: ExerciseExperimental Treatment1 Intervention

Six months of power training

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of Texas at AustinLead Sponsor

353 Previous Clinical Trials

81,184 Total Patients Enrolled

Media Library

Exercise (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT04641117 — N/A

Exercise Training and Sarcopenia Research Study Groups: Exercise

Exercise Training and Sarcopenia Clinical Trial 2023: Exercise Highlights & Side Effects. Trial Name: NCT04641117 — N/A

Exercise (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04641117 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research currently open to recruitment?

"It appears that, based on the information presented on clinicaltrials.gov, this particular trial is not currently enrolling individuals. Initial posting was done in January 2021 and the page has been updated as recently as November 2020; nevertheless, there are 107 other trials actively recruiting at present."

Answered by AI

Are adults aged 20 and over being invited to partake in this clinical trial?

"Potential applicants for this medical trial must between the ages of 60 and 80. Additionally, there are 1 studies available to those under 18 years old and 104 for seniors above 65."

Answered by AI

What qualifications are necessary for a person to qualify as an experiment participant?

"In order to be included in this clinical trial, individuals must suffer from sarcopenia and should fall between the ages of 60 and 80. The research team is currently searching for around sixty participants."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Time Efficient Exercise to Reverse Sarcopenia and Improve Cardio-metabolic Health

2021. "Time Efficient Exercise to Reverse Sarcopenia and Improve Cardio-metabolic Health". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04641117.

All > Sarcopenia